- Home
- OSUR vs DHY Comparison
OSUR vs DHY Comparison
Compare OSUR & DHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSUR
- DHY
- Stock Information
- Founded
- OSUR 2000
- DHY 1998
- Country
- OSUR United States
- DHY United States
- Employees
- OSUR N/A
- DHY N/A
- Industry
- OSUR Medical/Dental Instruments
- DHY Finance/Investors Services
- Sector
- OSUR Health Care
- DHY Finance
- Exchange
- OSUR Nasdaq
- DHY Nasdaq
- Market Cap
- OSUR 248.3M
- DHY 218.7M
- IPO Year
- OSUR 1986
- DHY N/A
- Fundamental
- Price
- OSUR $3.37
- DHY $2.12
- Analyst Decision
- OSUR Hold
- DHY
- Analyst Count
- OSUR 2
- DHY 0
- Target Price
- OSUR $5.50
- DHY N/A
- AVG Volume (30 Days)
- OSUR 699.3K
- DHY 569.1K
- Earning Date
- OSUR 05-07-2025
- DHY 01-01-0001
- Dividend Yield
- OSUR N/A
- DHY 9.10%
- EPS Growth
- OSUR N/A
- DHY N/A
- EPS
- OSUR N/A
- DHY N/A
- Revenue
- OSUR $185,827,000.00
- DHY N/A
- Revenue This Year
- OSUR N/A
- DHY N/A
- Revenue Next Year
- OSUR $7.46
- DHY N/A
- P/E Ratio
- OSUR N/A
- DHY N/A
- Revenue Growth
- OSUR N/A
- DHY N/A
- 52 Week Low
- OSUR $2.69
- DHY $1.77
- 52 Week High
- OSUR $6.35
- DHY $2.08
- Technical
- Relative Strength Index (RSI)
- OSUR 45.10
- DHY 41.50
- Support Level
- OSUR $3.34
- DHY $2.10
- Resistance Level
- OSUR $3.56
- DHY $2.15
- Average True Range (ATR)
- OSUR 0.15
- DHY 0.02
- MACD
- OSUR -0.00
- DHY -0.00
- Stochastic Oscillator
- OSUR 10.53
- DHY 25.00
Stock Price Comparison Chart: OSUR vs DHY
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
About DHY Credit Suisse High Yield Bond Fund
Credit Suisse High Yield Bond Fund is a non-diversified, closed-end management investment company to seeks high current income and capital appreciation as a secondary objective.